2, 5-disubstituted phenyl methanone derivatives as glycine transporter 1 (GlyT-I) inhibitors for the treatment of neurological and neuropsychiatry disorders

Details for Australian Patent Application No. 2006207650 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Norcross, Roger David; Narquizian, Robert; Pinard, Emmanuel; Jolidon, Synese

Agent Spruson & Ferguson

Pub. Number AU-B-2006207650

PCT Pub. Number WO2006/077026

Priority 05100280.6 18.01.05 EP

Filing date 10 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 27 January 2011

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4427 (2006.01) - containing further heterocyclic ring systems

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 207/12 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/46 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077026 Priority application(s): WO2006/077026

30 August 2007 Change of Name(s) of Applicant(s), Section 104

  F.Hofmann-La Roche AG The name of the applicant has been changed to F. Hofmann-La Roche AG

29 November 2007 Change of Name(s) of Applicant(s), Section 104

  F. Hofmann-La Roche Ltd. The name of the applicant has been changed to F. Hoffmann-La Roche Ltd.

27 January 2011 Application Accepted

  Published as AU-B-2006207650

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207652-Method and device for dimming lighting control devices to a predefined level

2006207649-Morpholines as 5HT2c agonists